Stanley Stern - Dec 4, 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role: Director
Signature: /s/ Jerome Wong, as Attorney-in-Fact
Stock symbol: EKSO
Transactions as of: Dec 4, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/6/2022, 06:04 PM
Previous filing: Jun 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EKSO	Common Stock	Award	$0	+87.8K	+110.81%	$0.00	167K	Dec 4, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The grant of restricted stock units ("RSUs") was approved by the Issuer's Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. The RSUs fully vested on December 4, 2022 and were delivered to the Reporting Person upon settlement.
F2	Includes 51,721 unvested RSUs.

Content

The grant of restricted stock units ("RSUs") was approved by the Issuer's Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. The RSUs fully vested on December 4, 2022 and were delivered to the Reporting Person upon settlement.

Includes 51,721 unvested RSUs.